AI-powered coding tools have become so popular over the past few months that almost every major tech company is either using one or making its own. Makers of these so-called “vibe-coding” tools are a ...

Coverage marks a pivotal step in expanding access to ultra-sensitive MRD detection for breast cancer patients U.S. Medicare coverage decision reflects published, peer-reviewed clinical data ...

Part of the Perforce Continuous Testing Platform, Perfecto AI generates execution-ready test actions from natural language prompts to validate applications across web, Android, and iOS. Seeking to ...

Cancer test maker Lucid Diagnostics (NASDAQ:LUCD), majority owned by PavMed (NASDAQ:PAVM), traded ~8% lower on Wednesday after the company said that a group of medical experts will meet in September ...

Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services ...